ArticleThoracic cancer2026

Systemic Inflammation Modifies the Efficacy of Bevacizumab Added to Atezolizumab Plus Chemotherapy for Advanced Non-Squamous Non-Small Cell Lung Cancer: A Multicenter Retrospective Study.

Keijiro Yamauchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.